News
Why Is Amkor Technology (AMKR) Up 2.9% Since Last Earnings Report?
It has been about a month since the last earnings report for Amkor Technology (AMKR). Shares have added about 2.9% in that time frame, underperforming the S&P 500.
But investors have to be
Here's Why Investors Should Bet on Wabtec Stock Right Now
Westinghouse Air Brake Technologies WAB, operating as Wabtec, has seen its top line bolstered by robust backlog growth, enhancing the company’s overall performance. Shareholder-friendly initiatives
Rising Costs & Expenses Pressure USAR: What's the Road Ahead?
USA Rare Earth, Inc. USAR remains in the early stages of commercial growth and continues to face losses as operations scale. While revenue generation has started following the acquisition of Less
Do Options Traders Know Something About LifeVantage Stock We Don't?
Investors in LifeVantage Corporation LFVN need to pay close attention to the stock based on moves in the options market lately. That is because the June 18, 2026 $15.00 Call had some of the highest
AJG Strengthens Specialty Insurance via Acquisition of Twin Elms
Arthur J. Gallagher & Co. AJG continues to expand its specialty insurance capabilities through the acquisition of Twin Elms, a Florida-based retail insurance broker specializing in environmental
ATRO vs. AIR: Which Aerospace Services Stock Offers Better Potential?
Growing aircraft deliveries worldwide, expanding airline fleet and rising demand for maintenance, repair and overhaul (MRO) services continue to support growth in the aviation services space. A
Capri Holdings Beats Q4 Earnings Estimates, Sees FY27 Growth Ahead
Capri Holdings Limited CPRI delivered fourth-quarter fiscal 2026 results, with revenues missing the Zacks Consensus Estimate and declining year over year. However, earnings surpassed the consensus
SoundHound's Automotive & IoT Business Jump 88%: Is Momentum Building?
SoundHound AI, Inc.’s SOUN automotive and IoT business showed strong organic momentum in the first quarter of 2026, with revenues surging 88% year over year, excluding acquisitions. This growth
Shake Shack Insiders Buy as SHAK Stock Faces More Pressure
Key Points
- Interested in Shake Shack, Inc.? Here are five stocks we like better.
- Shake Shack insiders are buying stock in a show of confidence that may have come too early.
- The stock price is set
Qualcomm's TikTok AI Chip Deal Rewrites the Rules
Key Points
- Interested in Qualcomm Incorporated? Here are five stocks we like better.
- Qualcomm secured a multi-million unit ASIC order from ByteDance, sending shares to an all-time high near $258
Movado Group Q1 Earnings Call Highlights
Key Points
- Interested in Movado Group Inc.? Here are five stocks we like better.
- Movado Group posted a strong first quarter, with net sales up 8.1% to $142.4 million and adjusted EPS rising to
Dycom Industries Q1 Earnings Call Highlights
Key Points
- Interested in Dycom Industries, Inc.? Here are five stocks we like better.
- Dycom delivered a strong fiscal Q1, with revenue up 56% year over year to $1.965 billion and adjusted
Capri Q4 Earnings Call Highlights
Key Points
- Interested in Capri Holdings Limited? Here are five stocks we like better.
- Capri returned to profitability in fiscal Q4, posting net income of $27 million, or $0.22 per share, as
BDTX Broadens EGFR Reach into Glioblastoma, Adding a Fresh Catalyst
Black Diamond Therapeutics BDTX is widening the opportunity set for silevertinib by pushing beyond lung cancer and into glioblastoma, a move that leans on the same core attribute that has driven
Black Diamond Stock Outlook After Q1 Beat and Cash Runway
Black Diamond Therapeutics BDTX delivered a modest first-quarter earnings beat, but the stock’s story remains almost entirely clinical. Investors are underwriting one main question: can silevertinib
BDTX Silevertinib Data in EGFR NSCLC: What Investors Need to Know
Black Diamond Therapeutics BDTX is building its equity story around one drug, silevertinib, a brain-penetrant, fourth-generation EGFR inhibitor being studied in EGFR–mutant non-small cell lung
Is it Worth Retaining Veracyte Stock in Your Portfolio for Now?
Veracyte VCYT is well poised to grow in the upcoming quarters owing to its ongoing sales momentum of Afirma and Decipher Prostate tests. Meanwhile, operational headwinds from macroeconomic pressures
Can Ericsson's 5G Innovation Network in Canada Drive Future Growth?
Ericsson ERIC has partnered with the Government of Canada to launch the Advanced Wireless Communications Innovation Network (AWIN), a new 5G platform focused on strengthening the country’s defense
Is Molina Healthcare Worth Buying at a Premium 26.83X P/E Valuation?
Molina Healthcare, Inc. MOH is a multi-state managed care organization that provides healthcare services under Medicaid, Medicare and state insurance marketplaces. The company operates through four
Modine Q4 Earnings Beat Estimates on Data Center Demand
Modine Manufacturing Company MOD posted adjusted earnings of $1.71 per share for the fourth quarter of fiscal 2026, which increased 53% from the year-ago quarter and came above the Zacks Consensus
WTI Crude Lowest in Five Weeks
News this morning is keeping pre-market futures alight while sending spot oil prices down: Iran State TV is openly discussing a draft for a peace deal with the U.S. that would end the war begun in
PODD and Omnipod 5: What's Driving Insulet's 2026 Growth
Insulet Corporation PODD is leaning on Omnipod 5 momentum to open 2026 with a faster growth profile than most medical products peers. Demand across Type 1 diabetes and early Type 2 diabetes is the





.jpg?locale=us)